Feb. 12, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ ... today announced the resignation of Chief Executive Officer (CEO) Mark Iwicki, and the appointment of Todd Bazemore, KALA's President ...
Feb. 12, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical ... today announced the resignation of Chief Executive Officer (CEO) Mark Iwicki, and the appointment ...
Feb. 12, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ ... today announced the resignation of Chief Executive Officer (CEO) Mark Iwicki, and the appointment of Todd Bazemore, KALA’s President ...
GlobalData on MSN11d
EC grants marketing authorisation to BridgeBio’s ATTR-CM treatmentEC has granted marketing authorisation to BridgeBio Pharma’s acoramidis under the Beyonttra brand name for treating ATTR-CM.
Prior to joining Iovance, Mr. Kirby led global commercial strategy for an emerging cell therapy platform of products as Chief Commercial Officer of Orca Bio. From 2018 to 2020 ... reimbursement and ...
Prior to joining Iovance, Mr. Kirby led global commercial strategy for an emerging cell therapy platform of products as Chief Commercial Officer of Orca Bio ... and marketing efforts for CAR ...
MINNEAPOLIS (Jan. 29, 2025)-- Peytant Solutions Inc., a medical technology company pioneering the use of amnion-based covered scaffolds for the treatment of luminal disease, announces the appointment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback